| Budget Amount *help |
¥18,850,000 (Direct Cost: ¥14,500,000、Indirect Cost: ¥4,350,000)
Fiscal Year 2011: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2010: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
Fiscal Year 2009: ¥7,020,000 (Direct Cost: ¥5,400,000、Indirect Cost: ¥1,620,000)
|
|---|
| Research Abstract |
In this study, we identified a novel omega-3 polyunsaturated fatty acid-derived anti-inflammatory mediator 17, 18-diHEPE, termed resolvin E3(RvE3). The chemical structure of RvE3 was determined by LC-MS/MS-based lipidomics, stereoselective organic synthesis, and high-resolution NMR. Unlike previously identified RvE1 and RvE2, both of which are biosynthesized by neutrophils via 5-LOX pathway, RvE3 was biosynthesized by eosinophils via 12/15-LOX pathway. RvE3 at nanogram dosages displayed a potent anti-inflammatory action in vivo by limiting neutrophil infiltration in zymosan-induced peritonitis. These findings propose a novel metabolic cascade for the beneficial actions of omega-3 fatty acid in controlling inflammation and related diseases
|
